📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Entheon Biomedical

1.1 - Company Overview

Entheon Biomedical Logo

Entheon Biomedical

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology research and development focused on developing and commercializing safe and effective DMT-based psychedelic therapeutic products to treat addiction and substance use disorders, subject to regulatory approvals; an addiction recovery solution harnessing and optimizing the therapeutic potential of the DMT molecule.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Entheon Biomedical

Longeviti Neuro Solutions Logo

Longeviti Neuro Solutions

HQ: United States Website
  • Description: Provider of implantable neurosurgical devices, developing and commercializing these products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Longeviti Neuro Solutions company profile →
Synchroneuron Logo

Synchroneuron

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies under development for tardive dyskinesia and other related movement disorders, including lead candidate SNC-102, a sustained-release formulation of acamprosate calcium in phase 2 trials for tardive dyskinesia and Tourette syndrome.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synchroneuron company profile →
Cybin Logo

Cybin

HQ: Canada Website
  • Description: Provider of clinical-stage psychedelic-based therapeutics for mental health conditions, including CYB003, a deuterated psilocybin analog for Major Depressive Disorder with positive Phase 2 data, and CYB004, a deuterated DMT molecule aimed at treating Generalized Anxiety Disorder, with a US Phase 2 study expected to begin.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cybin company profile →
Addex Therapeutics Logo

Addex Therapeutics

HQ: Switzerland Website
  • Description: Provider of clinical-stage, orally available small-molecule allosteric modulators. Pipeline includes ADX71149, an mGlu2 positive allosteric modulator in Phase 2 for epilepsy; dipraglurant, an mGlu5 negative allosteric modulator for post-stroke/TBI sensorimotor recovery; and GABAB PAM programs for substance use disorder (licensed to Indivior) and chronic cough.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Addex Therapeutics company profile →
Alector Logo

Alector

HQ: United States Website
  • Description: Provider of neuroimmunology- and human genetics-informed antibody therapeutics for neurodegenerative diseases, with a pipeline including AL001 (targets progranulin for frontotemporal dementia with granulin mutation, Phase 3), AL002 (targets TREM2 to enhance microglia for Alzheimer's, Phase 2b), AL101 (increases progranulin for Alzheimer's/Parkinson's, Phase 2), and preclinical ABC candidates ADP027-ABC (GPNMB) and ADP050-ABC (GCase).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alector company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Entheon Biomedical

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Entheon Biomedical

2.2 - Growth funds investing in similar companies to Entheon Biomedical

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Entheon Biomedical

4.2 - Public trading comparable groups for Entheon Biomedical

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Entheon Biomedical

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Entheon Biomedical

What does Entheon Biomedical do?

Entheon Biomedical is a provider of biotechnology research and development focused on developing and commercializing safe and effective DMT-based psychedelic therapeutic products to treat addiction and substance use disorders, subject to regulatory approvals; an addiction recovery solution harnessing and optimizing the therapeutic potential of the DMT molecule.

Who are Entheon Biomedical's competitors?

Entheon Biomedical's competitors and similar companies include Longeviti Neuro Solutions, Synchroneuron, Cybin, Addex Therapeutics, and Alector.

Where is Entheon Biomedical headquartered?

Entheon Biomedical is headquartered in Canada.

How many employees does Entheon Biomedical have?

Entheon Biomedical has 1,000 employees 🔒.

When was Entheon Biomedical founded?

Entheon Biomedical was founded in 2010 🔒.

What sector and industry vertical is Entheon Biomedical in?

Entheon Biomedical is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Entheon Biomedical

Who are the top strategic acquirers in Entheon Biomedical's sector and industry

Top strategic M&A buyers and acquirers in Entheon Biomedical's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Entheon Biomedical?

Top strategic M&A buyers groups and sectors for Entheon Biomedical include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Entheon Biomedical's sector and industry vertical

Which are the top PE firms investing in Entheon Biomedical's sector and industry vertical?

Top PE firms investing in Entheon Biomedical's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Entheon Biomedical's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Entheon Biomedical's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Entheon Biomedical's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Entheon Biomedical include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Entheon Biomedical's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Entheon Biomedical?

The key public trading comparables and valuation benchmarks for Entheon Biomedical include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Entheon Biomedical for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Entheon Biomedical with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Entheon Biomedical's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Entheon Biomedical with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Entheon Biomedical's' sector and industry vertical?

Access recent funding rounds and capital raises in Entheon Biomedical's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Entheon Biomedical